Evolent Health, Inc. (EVH)
NYSE: EVH · Real-Time Price · USD
11.31
-0.64 (-5.36%)
At close: Nov 20, 2024, 4:00 PM
11.60
+0.29 (2.56%)
After-hours: Nov 20, 2024, 7:19 PM EST
Evolent Health Market Cap
Evolent Health has a market cap or net worth of $1.30 billion as of November 21, 2024. Its market cap has decreased by -60.19% in one year.
Market Cap
1.30B
Enterprise Value
2.03B
1-Year Change
-60.19%
Ranking
Category
Stock Price
$11.31
Market Cap Chart
Since June 5, 2015, Evolent Health's market cap has increased from $1.05B to $1.30B, an increase of 23.72%. That is a compound annual growth rate of 2.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 1.32B | -65.28% |
| Dec 29, 2023 | 3.80B | 33.63% |
| Dec 30, 2022 | 2.84B | 14.85% |
| Dec 31, 2021 | 2.47B | 79.93% |
| Dec 31, 2020 | 1.38B | 79.57% |
| Dec 31, 2019 | 765.70M | -53.32% |
| Dec 31, 2018 | 1.64B | 72.46% |
| Dec 29, 2017 | 951.20M | -5.38% |
| Dec 30, 2016 | 1.01B | 40.70% |
| Dec 31, 2015 | 714.50M | -32.05% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| InMode | 1.51B |
| Travere Therapeutics | 1.51B |
| Spyre Therapeutics | 1.47B |
| BioCryst Pharmaceuticals | 1.46B |
| Intellia Therapeutics | 1.44B |
| Bicycle Therapeutics | 1.41B |
| Myriad Genetics | 1.39B |
| Syndax Pharmaceuticals | 1.38B |